Rothschild & Co Asset Management US’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-136,604
| Closed | -$8.34M | – | 293 |
|
|
2020
Q4 | $8.34M | Buy |
136,604
+2,165
| +2% | +$132K | 0.11% | 206 |
|
|
2020
Q3 | $6.29M | Buy |
134,439
+4,652
| +4% | +$217K | 0.11% | 224 |
|
|
2020
Q2 | $6.59M | Buy |
129,787
+1,793
| +1% | +$91K | 0.1% | 247 |
|
|
2020
Q1 | $5.71M | Buy |
127,994
+109,701
| +600% | +$4.89M | 0.09% | 247 |
|
|
2019
Q4 | $879K | Sell |
18,293
-847
| -4% | -$40.7K | 0.01% | 324 |
|
|
2019
Q3 | $647K | Buy |
19,140
+2,043
| +12% | +$69.1K | 0.01% | 328 |
|
|
2019
Q2 | $769K | Sell |
17,097
-228
| -1% | -$10.3K | 0.01% | 326 |
|
|
2019
Q1 | $652K | Sell |
17,325
-14,367
| -45% | -$541K | 0.01% | 345 |
|
|
2018
Q4 | $1.09M | Buy |
31,692
+3,439
| +12% | +$118K | 0.01% | 348 |
|
|
2018
Q3 | $1.33M | Buy |
+28,253
| New | +$1.33M | 0.01% | 347 |
|